Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No intervention.
- Who it may be relevant to
- Registry conditions: Cancer Screening, Transgender, Gender Diverse Populations. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future
Interventions
- Other No intervention
Observational study
Primary outcome measures
- Rates of cervical cancer screening and endometrial sampling in TGD individuals [Time frame: Month 36]
- Whether HPV self-testing affects the rates of cervical cancer screening in TGD individuals [Time frame: Month 36]
Secondary outcome measures (2)
- how introducing the option of HPV self-testing affects the rates of cervical cancer screening in TGD individuals undergoing hysterectomy. [Time frame: Month 36]
- how introducing the option of HPV self-testing affects patient experience [Time frame: Month 36]
Eligibility criteria
Inclusion criteria
- 18 years and older
- Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent
- Able to understand, speak, read, and write in English
- Patients who have undergone hysterectomy, or plan to have a hysterectomy
- Patients who are transgender and gender diverse"
Exclusion criteria
- Opted out of research
- <18 years old
- Lacks capacity to consent/has diminished capacity to consent
- Cannot provide informed consent
- Those on the study's community advisory board
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- University of Minnesota — Minneota
Identifiers
NCT: NCT07075731 · 2023LS213